analysis of long-term survival in a large apl patient cohort: a harmony alliance study
Published 1 year ago • 192 plays • Length 3:19Download video MP4
Download video MP3
Similar videos
-
2:19
maintaining remission in aml and improving long-term survival in patients who do not receive hsct
-
1:16
predictors of long-term survival in patients with dlbcl/hgbcl following autosct
-
1:57
combining molecular and clinical data to predict survival & transformation risk in patients with mds
-
3:54
an insight into how novel agents are influencing survival outcomes in patients with mf
-
1:15
outcomes of non-intensive chemotherapy differ for idh1 and idh2-mutated aml
-
6:45
novel scoring system defines allo-hsct patients at high risk for cmv
-
3:30
clinical value of event-free survival in aml
-
1:44
diagnostic yield of a new multigene panel test in patients with suspected cardiac amyloidosis
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:05
alnuctamab: improved route of administration and optimized dose level & dosing schedule
-
1:16
insights into an oncology simulation model being used to evaluate treatment regimens in hl
-
1:27
the harmony alliance: results from the proof-of-principle study for aml
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
1:47
individualized machine learning predictions of allosct outcomes in aml: the harmony platform
-
0:56
the main challenges facing practitioners treating apl
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:44
the molecular and microenvironmental basis of immunodysfunction in cll